retatrutide human trials Side Effects Research ESC 2024: Retatrutide improves lipid
Description
When estrogen levels decline during menopause, these systems may become less responsive
Subsequently, the mice were anesthetized, and blood samples were obtained from the intraorbital venous plexus
That drug, called retatrudide, is currently in clinical trials that indicate even greater achievable weight loss (up to 24%) compared to the original GLP-1 drugs (6-15%)
However, good news for weight-watchers and type-2 diabetics may concern re/insurers
